Motus GI Announces Pricing of Initial Public Offering

Motus GI a medical technology company dedicated to improving endoscopy outcomes and experiences, announced today the pricing of its initial public offering of 3,500,000 shares of its common stock at a public offering price of $5.00 per share. All of the shares of common stock are being offered by Motus. The shares are expected to begin trading on the NASDAQ Capital Market on February 14, 2018 under the ticker symbol “MOTS.”

As quoted in the press release:

 In addition Motus has granted the underwriters a 30-day option to purchase an additional 525,000 shares of its common stock at the initial public offering price, less the underwriting discount and commissions, to cover over-allotments. The closing of the offering is expected to occur on February 16, 2018, subject to the satisfaction of customary closing conditions. Piper Jaffray & Co. is acting as the sole book-running manager and Oppenheimer & Co. is acting as lead manager for the offering.

Click here to read the full press release.